1.
Khanam FM. Donepezil to lecanemab-advancements in targeted therapy of Alzheimer’s disease so far. Int J Adv Med [Internet]. 2023 Jul. 26 [cited 2025 Nov. 17];10(8):653-9. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/3872